290 related articles for article (PubMed ID: 7371029)
1. 1-beta-D-arabinofuranosylcytosine nucleotide inhibition of sialic acid metabolism in WI-38 cells.
Myers-Robfogel MW; Spataro AC
Cancer Res; 1980 Jun; 40(6):1940-3. PubMed ID: 7371029
[TBL] [Abstract][Full Text] [Related]
2. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity.
Abe I; Saito S; Hori K; Suzuki M; Sato H
Cancer Res; 1982 Jul; 42(7):2846-51. PubMed ID: 7083175
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosine.
Ueda T; Kamiya K; Urasaki Y; Wataya S; Kawai Y; Tsutani H; Sugiyama M; Nakamura T
Cancer Res; 1994 Jan; 54(1):109-13. PubMed ID: 8261429
[TBL] [Abstract][Full Text] [Related]
4. Sequence-specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template.
Townsend AJ; Cheng YC
Mol Pharmacol; 1987 Sep; 32(3):330-9. PubMed ID: 2444869
[TBL] [Abstract][Full Text] [Related]
5. [Antitumor activity of a novel analog of cytarabine, 4-amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 5'-(sodium octadecyl phosphate) monohydrate (YNK01)].
Nagahata T; Shibasaki C; Ishii T; Uchida T; Arakawa M; Kusama K; Ekimoto H; Takahashi K
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1437-45. PubMed ID: 2389942
[TBL] [Abstract][Full Text] [Related]
6. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
Riva CM; Rustum YM
Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
[TBL] [Abstract][Full Text] [Related]
7. Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosine.
Liliemark JO; Plunkett W; Dixon DO
Cancer Res; 1985 Nov; 45(11 Pt 2):5952-7. PubMed ID: 4053067
[TBL] [Abstract][Full Text] [Related]
8. 1-beta-D-arabinofuranosylcytosine-diphosphate-choline is formed by the reversal of cholinephosphotransferase and not via cytidylyltransferase.
Kucera GL; Capizzi RL
Cancer Res; 1992 Jul; 52(14):3886-91. PubMed ID: 1377599
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of DNA polymerase-alpha by ara-CMP in the presence of a regulatory protein extracted from human promyelocytic leukemic cells (HL-60).
Leclerc JM; Grisé-Miron L; Labonté L
Semin Oncol; 1987 Jun; 14(2 Suppl 1):226-30. PubMed ID: 3473678
[TBL] [Abstract][Full Text] [Related]
10. Modulation of arabinosylnucleoside metabolism by arabinosylnucleotides in human leukemia cells.
Gandhi V; Plunkett W
Cancer Res; 1988 Jan; 48(2):329-34. PubMed ID: 3335008
[TBL] [Abstract][Full Text] [Related]
11. Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5'-triphosphate.
Liliemark JO; Plunkett W
Cancer Res; 1986 Mar; 46(3):1079-83. PubMed ID: 3484676
[TBL] [Abstract][Full Text] [Related]
12. Deoxyribonucleoside triphosphate pools and Ara-CTP levels in P388 murine leukemic cells treated with 1-B-D-arabinofuranosylcytosine-5'-stearylphosphate which is a newly synthesized derivative of 1-B-D-arabinofuranosylcytosine.
Higashigawa M; Hori H; Ohkubo T; Kawasaki H; Yoshizumi T; Sakurai M
Med Oncol Tumor Pharmacother; 1990; 7(4):223-6. PubMed ID: 2283889
[TBL] [Abstract][Full Text] [Related]
13. Effects of pyrimidine antagonists on sialic acid regeneration in HL-60 cells.
Hindenburg AA; Taub RN; Grant S; Chang G; Baker MA
Cancer Res; 1985 Jul; 45(7):3048-52. PubMed ID: 3859365
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy.
Plunkett W; Hug V; Keating MJ; Chubb S
Cancer Res; 1980 Mar; 40(3):588-91. PubMed ID: 6937239
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hepatitis B virus deoxyribonucleic acid polymerase by the 5'-triphosphates of 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine.
Hess G; Arnold W; Meyer zum Büschenfelde KH
Antimicrob Agents Chemother; 1981 Jan; 19(1):44-50. PubMed ID: 6166246
[TBL] [Abstract][Full Text] [Related]
16. Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution.
Ross DD; Chen SR; Cuddy DP
Cancer Res; 1990 May; 50(9):2658-66. PubMed ID: 2328491
[TBL] [Abstract][Full Text] [Related]
17. A new sensitive method for determination of intracellular 1-beta-D-arabinofuranosylcytosine 5'-triphosphate content in human materials in vivo.
Yamauchi T; Ueda T; Nakamura T
Cancer Res; 1996 Apr; 56(8):1800-4. PubMed ID: 8620496
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo.
Chou TC; Hutchinson DJ; Schmid FA; Philips FS
Cancer Res; 1975 Jan; 35(1):225-36. PubMed ID: 1109791
[TBL] [Abstract][Full Text] [Related]
19. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on elongation of specific DNA sequences by DNA polymerase beta.
Ohno Y; Spriggs D; Matsukage A; Ohno T; Kufe D
Cancer Res; 1988 Mar; 48(6):1494-8. PubMed ID: 3345522
[TBL] [Abstract][Full Text] [Related]
20. Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy.
Gandhi V; Estey E; Du M; Keating MJ; Plunkett W
Clin Cancer Res; 1997 Sep; 3(9):1539-45. PubMed ID: 9815841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
